{"timestamp": 1771604719.0278282, "value": {"ticker": "SKYE", "company_name": "Skye Bioscience, Inc.", "short_name": "Skye Bioscience, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 24581660, "float_shares": 19882037, "shares_outstanding": 32057461, "short_ratio": 2.6, "short_percent_of_float": 0.0468, "shares_short": 1014976, "shares_short_prior": 998730, "insider_percent_held": 0.013940001, "institution_percent_held": 0.50321996, "total_cash": 35312308, "total_debt": 321845, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 0.98, "current_ratio": 4.771, "book_value": 1.06, "price_to_book": 0.72339624, "operating_cashflow": -41469144, "free_cashflow": -14401440, "price": 0.7668, "52w_high": 5.75, "52w_low": 0.684, "avg_volume": 390571, "avg_volume_10d": 422970, "full_time_employees": 16, "audit_risk": 0, "overall_risk": 0}}